WNT10B and hepatocellular carcinoma: Delivery of miR-192 via hydrogel-based methods inhibits hepatocellular carcinoma progression by specifically targeting WNT10B, encoding Wnt Family Member 10B protein (WNT10B) which plays a crucial role in the GSK3β/Wnt/β-catenin pathway [112].